Concepedia

Jacques Yves Gauthier

JY

Statistics

Publications

39

Citations

2.4K

H-Index

26

Active since

1961

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

TransCanada (Canada)

United States Military Academy

University of British Columbia

Jacques Yves Gauthier is an author at Merck Canada Inc. (Canada) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1961–2017

39

Publications

39

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 473 citations · Full text

, , +10

Practical Route to a New Class of LTD<sub>4</sub> Receptor Antagonists

Robert D. Larsen, Edward G. Corley, Anthony O. King et al. · The Journal of Organic Chemistry · 1996 · 225 citations

, , +6

French Registry on Acute ST-elevation and non−ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data

Loïc Belle, Guillaume Cayla, Yves Cottin et al. · Archives of cardiovascular diseases · 2017 · 135 citations

, , +15

2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors

Richard W. Friesen, Christine Brideau, Chi Chung Chan et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 128 citations · Full text

, , +9

Difluoroethylamines as an amide isostere in inhibitors of cathepsin K

Élise Isabel, Christophe Mellon, Michael J. Boyd et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 111 citations · Full text

, , +12

1–5 of 39